Stock research
HURA TuHURA Biosciences, Inc.
Healthcare • Biotechnology
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to...…
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
1Y change
-18.02%
Range high
$3.25
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in HURA?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $2.04
- Day High
- $2.15
- Day Low
- $2.09
- 52w High
- $3.90
- 52w Low
- $0.41
- Volume
- 154,548
- Avg Volume
- Beta
- -0.042762067
* TTM/most recent where available
Company
- Ticker
- HURA
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- James A. Bianco
- Employees
- 22
- Website
- www.tuhurabio.com
Key Metrics
- Market Cap
- 135M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).